First Page | Document Content | |
---|---|---|
![]() Date: 2015-02-25 13:15:39Staphylococcaceae Bacterial diseases Eli Lilly and Company Glycopeptide antibiotics Vancomycin Staphylococcus aureus Antibiotic resistance Oritavancin Chloramphenicol Bacteria Gram-positive bacteria Microbiology | Add to Reading List |
![]() | BMJ 2015;350:h1453 doi: [removed]bmj.h1453 Page 1 of 4 FeatureDocID: ZIyM - View Document |
![]() | ARTICLE doi:[removed]nature14098 A new antibiotic kills pathogens without detectable resistanceDocID: Y3Ud - View Document |
![]() | Variation of registered chemical product Rilexine 75 Palatable Flavoured Cephalexin Antibiotic tablets for cats and dogs - Advice SummaryDocID: Tpnr - View Document |
![]() | Rationale for new or revised EUCAST clinical breakpoints Derek Brown ECCMID 2011, Milan Setting breakpoints in EUCASTDocID: Ojlc - View Document |
![]() | Date Manufacturer Product Indication Biologic or Drug Reason/Comments[removed] JNJ Paliperidone Palmitate Schizophrenia Drug N/A[removed] BioDelivery Sciences Bema Fentanyl, which will be marketed in the US as OnsolisDocID: ByuJ - View Document |